STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
07.04.2015 14:18
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
1. BNP Paribas Investment Partners UK Limited
BNP Paribas Investment Partners UK Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 31 March 2015, that on 30 March 2015
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001 went above the threshold of 3% and that the percentage
of voting rights on that day amounted to 3.06% (360,672 voting rights). BNP
Paribas Investment Partners UK Limited has notified us that these voting
rights of 3.06% (360,672 voting rights) are attributable to BNP Paribas
Investment Partners UK Limited pursuant to sec. 22 para. 1 sent. 1 no. 6
WpHG.
The voting rights were attributed to BNP Paribas Investment Partners UK
Limited inter alia from BNP Paribas Investment Partners Belgium S.A., being
a shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
2. BNP Paribas Investment Partners Belgium S.A.
BNP Paribas Investment Partners Belgium S.A., Brussels, Belgium, has
notified us pursuant to sec. 21 para. 1 WpHG on 31 March 2015, that on 30
March 2015 the share of voting rights in STRATEC Biomedical AG, Birkenfeld,
Germany, ISIN: DE0007289001 went above the threshold of 3% and that the
percentage of voting rights on that day amounted to 3.06% (360,672 voting
rights).
07.04.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back